July 13, 2020
Weil is advising Churchill Capital Corp III, a SPAC sponsored by Churchill Capital Group, in its $11 billion merger with MultiPlan, Inc., a market-leading, technology-enabled provider of end-to-end healthcare cost management solutions. The transaction is expected to be completed by the end of October 2020, subject to approvals and other customary closing conditions.
The Weil team advising Churchill Capital Corp III is led by Mergers & Acquisitions partners Michael Aiello and Matthew Gilroy and includes Mergers & Acquisitions partner Amanda Fenster, Mergers & Acquisitions counsel Megan Pendleton and Mergers & Acquisitions associates Damian Petrovic, Stephen Liebscher, Robert Duff and Sam de Blecourt (Not Yet Admitted in New York). The team also includes Tax partner Devon Bodoh; Executive Compensation & Benefits Head Paul Wessel; Capital Markets partner Michael Hickey; Technology & IP Transactions Head Michael Epstein; Public Company Advisory Group partner Adé Heyliger; International Arbitration & Trade partner Ted Posner; Real Estate counsel Cynthia Resnick; Regulatory Transactions counsel John O’Loughlin; Antitrust counsel Michael Naughton; Tax associates Alfonso Dulcey and Charlie Roarty; Executive Compensation & Benefits associate Radhika Tahiliani; Capital Markets associates Alla Khabinskaya and Morgan Lloyd; Technology & IP Transactions associate Catherine Kim; and Cybersecurity, Data Privacy & Information Management associate Robert Brown.